Streptomyces atroolivaceus: NCBI 66869, [species]

Back to details

| "Actinomyces atroolivaceus" Preobrazhenskaya et al. 1957| Actinomyces atroolivaceus| AS 4.1405| ATCC 19725| BCRC 12073| CBS 464.68| CCRC 12073| CCRC:12073| CCUG 11112| CECT 3316| DSM 40137| IFO 12741| IMET 43088| INA 4776| ISP 5137| JCM 4345| KCTC 9017| LMG 19306| LMG:19306| NBRC 12741| NRRL-ISP 5137| RIA 1006| Streptomyces atroolivaceus| Streptomyces atroolivaceus (Preobrazhenskaya et al. 1957) Pridham et al. 1958| UNIQEM 121| VKM Ac-970

  1. Infective endocarditis: Streptococcus gallolyticus subsp. gallolyticus is one of the leading causes of infective endocarditis, particularly in individuals with underlying heart conditions or predisposing factors such as damaged heart valves.

  2. Colorectal cancer: There is evidence to suggest an association between Streptococcus gallolyticus subsp. gallolyticus infection and colorectal cancer. Individuals with colorectal cancer have been found to have higher rates of colonization with this bacterium compared to healthy individuals.

  3. Bacteremia: Streptococcus gallolyticus subsp. gallolyticus can also cause bacteremia, which is the presence of bacteria in the bloodstream. Bacteremia caused by this bacterium is often associated with underlying gastrointestinal conditions, such as inflammatory bowel disease or colorectal cancer.

  4. Gastrointestinal infections: In rare cases, Streptococcus gallolyticus subsp. gallolyticus may cause gastrointestinal infections, including diarrhea and abdominal pain, particularly in individuals with compromised immune systems.

Other Sources for more information:

You do not have any samples under this email

📹Video Walkthru of this Page

Streptomyces atroolivaceus impacts on other bacteria of the same rank

Other bacteria of the same rank impacting Streptomyces atroolivaceus

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]